- The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)Timothy J Bell
GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA
Pain Med 10:35-42. 2009..This multinational, Internet-based survey was designed to assess the prevalence, frequency, severity, and impact of opioid-induced bowel dysfunction (OBD) in patients receiving opioid therapy for chronic pain and taking laxatives...
- Economic analysis of alvimopan in North American Phase III efficacy trialsTimothy J Bell
GlaxoSmithKline, Research Triangle Park, NC 27709, USA
Am J Health Syst Pharm 66:1362-8. 2009..The economic effect of the use of alvimopan in four randomized, double-blind, placebo-controlled, Phase III, North American efficacy trials was analyzed...